Evidence map›Paper›PMID 31941579›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2020

Assessment of the Progression of Poststroke Depression in Ischemic Stroke Patients Using the Patient Health Questionnaire-9.

Lauren E Fournier, Jennifer E Sanner Beauchamp, Xu Zhang, Esther Bonojo, Mary Love, Gabretta Cooksey, Evelyn Hinojosa, Munachi N Okpala, Sean I Savitz, Anjail Z Sharrief

Open access · greenAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lauren E FournierThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas. Electronic address: Lauren.E.Fournier@uth.tmc.edu.
Jennifer E Sanner BeauchampCizik School of Nursing, The Institute for Stroke and Cerebrovascular Diseases, The University of Texas Health Science Center at Houston, Houston, Texas.
Xu ZhangCenter for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, Texas.
Esther BonojoThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
Mary LoveCizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas.
Gabretta CookseyThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
Evelyn HinojosaThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
Munachi N OkpalaThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
Sean I SavitzThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
Anjail Z SharriefThe Institute for Stroke and Cerebrovascular Diseases, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas.
The University of Texas Health Science Center at Houston · USThe University of Texas Health Science Center · US

Funding

THE UNIVERSITY OF TEXAS HOUSTON STROKE TRAINING PROGRAMT32NS007412 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVITZ, SEAN I · 1998 to 2023
$4.6M
NINDS NIH HHS T32 NS007412
6 · The paper itself

Abstract

backgroundPoststroke depression (PSD) affects one-third of stroke patients and is linked with higher stroke morbidity, mortality, and recurrence. Current guidelines do not direct when to screen for PSD, and predictors of PSD are not well understood. We sought to understand progression of PSD symptoms early after ischemic stroke, identify predictors of PSD, and describe the use of antidepressants in PSD.

methodsWe collected demographic, clinical, and PSD (Patient Health Questionnaire-9; PHQ-9) data from ischemic stroke patients hospitalized at our Comprehensive Stroke Center and followed up in our clinic. PHQ-9 was obtained during hospitalization and again in clinic within 180 days of discharge. We performed univariate analysis and logistic regression to detect variables associated with PSD.

resultsAmong 201 patients, PSD symptoms (PHQ-9 > 4) were identified in 30% of patients during hospitalization and 46% during follow-up (54% of which had no symptoms during hospitalization). At follow-up, 36% were worse by PHQ-9 category. In univariate analysis, follow-up modified Rankin Scale (mRS) greater than or equal to 2 (P = .03) and antidepressant prescription (P < .001) were associated with worsening PHQ-9 category. In logistic regression analysis, follow-up mRS greater than or equal to 2 (P = .02), posterior circulation stroke (P = .03), and antidepressant prescription (P < .01) were associated with worsening PHQ-9 category.

conclusionsAlmost half of ischemic stroke patients develop PSD symptoms and more than one-third worsen between hospitalization and follow-up. Poststroke disability (mRS ≥ 2) and posterior circulation stroke were associated with worsening PSD. Worsening PSD symptoms prompted treatment change in 29% of patients. Screening for PSD during hospitalization should be repeated during early follow-up.

Indexed as

AffectPatient Health QuestionnaireAgedAntidepressive AgentsBrain IschemiaDepressionDisability EvaluationDisease ProgressionFemaleHospitalizationHumansMaleMiddle AgedPredictive Value of TestsRisk AssessmentRisk FactorsAntidepressive AgentsdepressionIschemic strokepredictionprogressionsecondary prevention

Identifiers

PMID31941579
PMCPMC7243614
OpenAlexW2999860360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.